AGL Stock Up 45% after 6-Day Win Streak
Agilon Health (AGL) stock hit day 6 of a continuous streak of days with gains, with cumulative gains over this period amounting to a 45% return. The company has gained about $232 Mil in value over the last 6 days, with its current market capitalization at about $517 Mil. The stock remains 34.2% below its value at the end of 2024. This compares with year-to-date returns of 9% for the S&P 500.
AGL provides healthcare services for seniors through primary care physicians, serving approximately 238,000 senior members, including 186,300 Medicare Advantage members in U.S. communities. After this rally, is AGL still a buy – or is it time to lock in gains? Deep dive with Buy or Sell AGL.
Comparing AGL Stock Returns With The S&P 500
The following table summarizes the return for AGL stock vs. the S&P 500 index over different periods, including the current streak:
- The Options Market Says Adobe Stock Can Fall Over A Third Or Rise More Than Half
- Eli Lilly Stock’s Next Climb Runs Through A Pill, Not Just An Injection
- CoreWeave Stock Rallied Ahead Of Its Own Numbers, Not On Them
- Qualcomm’s Android Growth Number Has Left The Front Of The Story
- Micron Technology Stock Surged On A Shortage The Company Had Already Described
- The Real Upside Case For Mastercard Stock Is In The Plumbing
| Return Period | AGL | S&P 500 |
|---|---|---|
| 1D | 1.6% | -0.6% |
| 6D (Current Streak) | 44.8% | 0.6% |
| 1M (21D) | -41.6% | 1.7% |
| 3M (63D) | -46.6% | 7.5% |
| YTD 2025 | -34.2% | 9.0% |
| 2024 | -84.9% | 23.3% |
| 2023 | -22.2% | 24.2% |
| 2022 | -40.2% | -19.4% |
What is the point? Momentum often precedes conviction. A multi-day win streak can signal growing investor confidence or spark follow-on buying. Tracking such trends can help you ride the strength, or prepare for a well-timed entry if momentum fades. However, big gains can follow sharp reversals – but how has AGL behaved after prior drops? See AGL Dip Buyer Analysis to learn more.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 44 S&P constituents with 3 days or more of consecutive gains and 32 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 28 | 8 |
| 4D | 4 | 20 |
| 5D | 3 | 3 |
| 6D | 7 | 1 |
| 7D or more | 2 | 0 |
| Total >=3 D | 44 | 32 |
Key Financials for Agilon Health (AGL)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $4.3 Bil | $6.1 Bil |
| Operating Income | $-232.1 Mil | $-288.5 Mil |
| Net Income | $-262.6 Mil | $-260.2 Mil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ1 | 2025 FQ2 |
|---|---|---|
| Revenues | $1.5 Bil | $1.4 Bil |
| Operating Income | $-22.1 Mil | $-116.0 Mil |
| Net Income | $12.1 Mil | $-104.4 Mil |
While AGL stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 – the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.